Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2015-05-27Clinical Trial Update: Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia [Phase 2]
Phase 2 trial evaluating calcitriol to prevent prostate cancer in men with prostatic intraepithelial neoplasia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats [Phase 2]
Open-label Phase 2 trial assessing efficacy and safety of olaparib in patients with BRCA1/BRCA2 mutations across ovarian, breast, prostate, …
-
CLINICAL_TRIALS research · 2015-05-21Clinical Trial Update: Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided Biopsy [NA]
This clinical trial update describes a study comparing MRI/ultrasound fusion-guided prostate biopsy with standard systematic transrectal ult…
-
FDA approval · 2015-05-20FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ZYTIGA (abiraterone acetate) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy [NA]
Completed clinical trial comparing transurethral versus suprapubic urinary diversion after radical prostatectomy, focusing on pain and cathe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2015-05-19EMA Withdrawn: Provenge (autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor) — Dendreon UK Ltd
Dendreon’s Provenge has been withdrawn in Europe, with the therapeutic area listed as prostatic neoplasms.
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer
A clinical trial evaluating whether preoperative HbA1c levels affect pathologic features and oncological outcomes in patients with prostate …
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery [Phase 2]
Phase 2 trial evaluating metformin hydrochloride in patients with prostate cancer undergoing surgery has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Evaluation of the Effects of Different Prostate Surgeries on Urinary and Sexual Function [Phase 4]
A Phase 4 clinical trial evaluating how different prostate surgical procedures affect urinary and sexual function in adult men; the study ha…
-
FDA approval · 2015-05-08FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Leuprolide acetate submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a dose-escalation study of TH-302 in combination with gemcitabine, docetaxel, or pemetr…
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Personal Patient Profile Prostate (P4) Randomized, Multisite Trial [NA]
This document reports the completion of a multisite randomized trial evaluating the Personal Patient Profile Prostate (P4) in prostate cance…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study of a Polymorphism in Patients With Prostate Cancer
The clinical trial studying the impact of a polymorphism in patients with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial comparing vaccine therapy plus sargramostim and interleukin-2 versus nilutamide alone in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Flavopiridol in Treating Patients With Refractory Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of flavopiridol in patients with refractory cancers, including lymphoma, prostate canc…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Study Using WST11 in Patients With Localized Prostate Cancer [Phase 2]
Phase 2 study using WST11 (padoporfin) for localized prostate cancer has completed; the update does not include reported results.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) [Phase 1]
Phase 1 trial of MK0429 in prostate cancer with metastatic bone disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: An Alternative to A Fixed Schedule In Management Of Prostate Cancer
Completed clinical trial evaluating an alternative to a fixed scheduling approach in the management of prostate cancer.
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Shear Wave Elastography of Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating shear wave elastography for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating a combination of ketoconazole, hydrocortisone, and dutasteride in asymptomatic hormone-refractory prosta…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer
A completed clinical trial evaluating the use of extended pelvic lymphadenectomy to assess lymph node involvement in clinically localized pr…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
This clinical trial update describes factors that may influence disease progression and treatment outcomes in patients with tumors of the pr…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer [Phase 2]
A randomized phase II trial evaluating liposomal doxorubicin (Doxil) with or without dexamethasone in metastatic hormone-refractory prostate…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Prostate Cancer Education in African American Men [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a prostate cancer education program for African American men has completed. The document reports…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Fulvestrant in Treating Patients With Recurrent Prostate Cancer [Phase 2]
A Phase 2 trial evaluating the estrogen receptor antagonist fulvestrant for recurrent prostate cancer was terminated; results were posted in…